HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul W Armstrong Selected Research

Streptokinase

9/2013Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.
1/2011Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
2/2010Pharmacotherapy: Intracoronary streptokinase in acute myocardial infarction.
1/2008Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
9/2004Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
7/2004Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
8/2002Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?
7/2002Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul W Armstrong Research Topics

Disease

152Myocardial Infarction
05/2022 - 01/2002
113Acute Coronary Syndrome
11/2020 - 01/2002
110ST Elevation Myocardial Infarction
05/2022 - 01/2003
107Heart Failure
11/2022 - 01/2002
57Hemorrhage
01/2020 - 01/2002
45Stroke (Strokes)
01/2020 - 09/2003
27Infarction (Infarctions)
01/2021 - 09/2003
20Ischemia
03/2017 - 02/2002
16Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2002
16Unstable Angina
01/2020 - 01/2002
15Shock
05/2022 - 09/2003
12Hypertension (High Blood Pressure)
01/2021 - 01/2002
11Dyspnea (Shortness of Breath)
01/2018 - 02/2009
10Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2015
10Atrial Fibrillation
01/2021 - 08/2009
9Inflammation (Inflammations)
05/2022 - 12/2004
9Diabetes Mellitus
01/2021 - 11/2012
8Thrombosis (Thrombus)
05/2022 - 05/2002
8Coronary Disease (Coronary Heart Disease)
01/2019 - 05/2002
7Chest Pain (Chest Pains)
01/2017 - 04/2003
6Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020 - 12/2004
6Body Weight (Weight, Body)
01/2018 - 04/2005
6Cardiogenic Shock
08/2015 - 10/2005
6Necrosis
07/2012 - 07/2003
5Hypotension (Low Blood Pressure)
01/2022 - 11/2014
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 06/2002
5Atherosclerotic Plaque (Atheroma)
01/2019 - 05/2002
5Non-ST Elevated Myocardial Infarction
01/2018 - 05/2006
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2007 - 01/2002
4Cardiomyopathies (Cardiomyopathy)
01/2022 - 02/2015
4Renal Insufficiency (Renal Failure)
03/2016 - 03/2004
3Anemia
11/2021 - 10/2004
3Chronic Renal Insufficiency
01/2021 - 10/2016
3Vascular Diseases (Vascular Disease)
11/2020 - 01/2016
3Peripheral Arterial Disease
01/2020 - 10/2014
3Transient Ischemic Attack
05/2017 - 02/2010
3Acute Kidney Injury (Acute Renal Failure)
08/2016 - 10/2015

Drug/Important Bio-Agent (IBA)

45Brain Natriuretic Peptide (Natrecor)FDA Link
06/2021 - 04/2006
41pexelizumabIBA
11/2020 - 09/2003
37Biomarkers (Surrogate Marker)IBA
05/2022 - 07/2003
33Clopidogrel (Plavix)FDA Link
01/2020 - 01/2003
26Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 06/2002
22vericiguatIBA
11/2022 - 01/2018
21Prasugrel HydrochlorideFDA Link
01/2020 - 07/2010
19vorapaxarIBA
12/2018 - 01/2012
19Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2002
19Eptifibatide (Integrilin)FDA Link
04/2014 - 01/2002
18Thrombin Receptors (Thrombin Receptor)IBA
01/2020 - 01/2012
17CreatinineIBA
01/2020 - 12/2003
16pro-brain natriuretic peptide (1-76)IBA
01/2020 - 04/2006
16Enoxaparin (Lovenox)FDA LinkGeneric
07/2013 - 01/2003
15TenecteplaseFDA Link
01/2020 - 08/2003
14TroponinIBA
01/2020 - 04/2003
13Creatine Kinase (Creatine Phosphokinase)IBA
01/2020 - 01/2002
13MB Form Creatine KinaseIBA
10/2014 - 04/2003
13Complement System Proteins (Complement)IBA
09/2013 - 09/2003
11Sitagliptin Phosphate (Januvia)FDA Link
11/2020 - 07/2015
11Heparin (Liquaemin)FDA LinkGeneric
01/2007 - 01/2003
10Platelet Membrane GlycoproteinsIBA
10/2007 - 01/2002
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2017 - 08/2002
8Pharmaceutical PreparationsIBA
02/2016 - 01/2002
8StreptokinaseFDA Link
09/2013 - 07/2002
8Abciximab (ReoPro)FDA Link
07/2010 - 11/2002
7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020 - 08/2002
6paragonIBA
10/2007 - 02/2002
5Soluble Guanylyl CyclaseIBA
11/2022 - 01/2018
5DiureticsIBA
11/2022 - 12/2003
52'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 01/2016
5darapladibIBA
01/2019 - 05/2014
5Troponin IIBA
08/2018 - 04/2003
5EnzymesIBA
05/2014 - 01/2002
5Warfarin (Coumadin)FDA LinkGeneric
02/2010 - 04/2004
4Hemoglobins (Hemoglobin)IBA
11/2021 - 02/2005
4Peptide Hydrolases (Proteases)FDA Link
12/2018 - 03/2014
4Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2015 - 04/2004
4Platelet Membrane Glycoprotein IIbIBA
05/2015 - 12/2006
3Hormones (Hormone)IBA
06/2021 - 09/2010
3CytokinesIBA
01/2021 - 02/2007
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2005
3omega-Chloroacetophenone (Mace)IBA
01/2020 - 08/2016
3LDL CholesterolIBA
01/2020 - 08/2017
3Hypoglycemic Agents (Hypoglycemics)IBA
12/2019 - 01/2016
3HDL CholesterolIBA
01/2019 - 08/2014
3TicagrelorIBA
01/2018 - 01/2012
3Angiotensin Receptor AntagonistsIBA
09/2017 - 02/2006
3C-Reactive ProteinIBA
07/2017 - 10/2005
3NitrogenIBA
06/2017 - 01/2015
3Urea (Carbamide)FDA LinkGeneric
06/2017 - 01/2015
3SodiumIBA
06/2017 - 02/2015
3PAR-1 ReceptorIBA
12/2015 - 07/2014
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 04/2004

Therapy/Procedure

99Percutaneous Coronary Intervention
05/2022 - 09/2003
97Therapeutics
05/2022 - 01/2002
17Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 01/2002
16Thrombolytic Therapy
01/2020 - 02/2002
16Patient Readmission
12/2019 - 02/2009
6Length of Stay
01/2018 - 02/2004
4Secondary Prevention
12/2018 - 03/2003
4Stents
05/2016 - 01/2009
3Drug-Eluting Stents
09/2014 - 01/2009